Diesel Exhaust and Mechanism of Asthma
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This experiment is designed to test the hypothesis that oxidative stress is responsible for changes in airway responsiveness in humans exposed to diesel exhaust.
| Condition | Intervention |
|---|---|
|
Asthma |
Dietary Supplement: N-acetylcysteine Other: Diesel exhaust Other: Filtered air |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Effects of Diesel Exhaust on Airways |
- Human airway reactivity [ Time Frame: 50 hours ] [ Designated as safety issue: No ]Establish that oxidative stress is responsible for changes in human airway reactivity induced by DE (300 µg/m3 inhaled for two hours).
| Enrollment: | 26 |
| Study Start Date: | September 2007 |
| Study Completion Date: | October 2011 |
| Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Placebo Comparator: Filtered air with placebo
Exposure for 2 hours to filtered air and placebo tablets 3 times daily for 6 days
|
Other: Filtered air
A placebo tablet taken 3 times daily for 6 days prior to exposure to filtered air for 2 hours. The last supplement was taken the morning of the exposure
|
|
Active Comparator: Diesel exhaust with placebo
Exposure for 2 hours to diesel exhaust and placebo tablets 3 times daily for 6 days
|
Other: Diesel exhaust
A placebo tablet taken 3 times daily for 6 days prior to exposure to diesel exhaust for 2 hours. The last supplement was taken the morning of the exposure
|
|
Experimental: Diesel exhaust with N-acetylcysteine
Exposure for 2 hours to diesel exhaust and N-acetylcysteine tablets (600 mg) 3 times daily for 6 days
|
Dietary Supplement: N-acetylcysteine
N-acetylcysteine 600mg taken orally 3 times daily for 6 days prior to exposure to diesel exhaust for 2 hours. The last supplement was taken the morning of the exposure
Other: Diesel exhaust
A placebo tablet taken 3 times daily for 6 days prior to exposure to diesel exhaust for 2 hours. The last supplement was taken the morning of the exposure
|
Detailed Description:
The specific aim is to test the hypothesis that diesel exhaust (DE) increases airway reactivity via oxidative stress, particularly in asthmatics. To test this hypothesis, we use a crossover in vivo experimental model in mild asthmatics and normal controls using a state-of-the-art diesel exhaust exposure facility.
Participants took N-acetylcysteine (600 mg) or placebo capsules three times daily for six days. On the final morning of supplementation, participants were exposed for 2 hours to either filtered air or diesel exhaust (300 µg·m-3 of particulate matter smaller than 2.5 microns). Twenty-six non-smokers between 19-49 years were studied under three experimental conditions (filtered air with placebo, diesel exhaust with placebo and diesel exhaust with N-acetylcysteine) using randomized, double-blind, crossover design, with a two week minimum washout between conditions. Methacholine challenge was performed pre-exposure (to determine baseline airway responsiveness) and post-exposure (to determine the effect of exposure).
Eligibility| Ages Eligible for Study: | 19 Years to 49 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Between 19-49 years, non smokers, asthmatics, healthy controls
Exclusion Criteria:
- Smokers, pregnant or co-existing medical condition for which diesel exhaust would confer significant risk (i.e. coronary artery disease)
Contacts and Locations| Canada, British Columbia | |
| University of British Columbia | |
| Vancouver, British Columbia, Canada, V5Z1M9 | |
| Principal Investigator: | Christopher Carlsten, MD MPH | University of British Columbia |
More Information
Publications:
| Responsible Party: | University of British Columbia |
| ClinicalTrials.gov Identifier: | NCT01699204 History of Changes |
| Other Study ID Numbers: | H08-02288 |
| Study First Received: | October 1, 2012 |
| Last Updated: | October 1, 2012 |
| Health Authority: | Canada: Health Canada |
Keywords provided by University of British Columbia:
|
Air pollution Diesel exhaust Airway responsiveness Asthma Anti-oxidant |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases Acetylcysteine N-monoacetylcystine Antiviral Agents |
Anti-Infective Agents Therapeutic Uses Pharmacologic Actions Expectorants Respiratory System Agents Free Radical Scavengers Antioxidants Molecular Mechanisms of Pharmacological Action Protective Agents Physiological Effects of Drugs Antidotes |
ClinicalTrials.gov processed this record on May 23, 2013